Last reviewed · How we verify

NCT04363125

Review of Isolated Hypoganglionosis and Presentation of a New Case Complicated With Sigmoid Volvulus

Completed Last updated 28 April 2020
What this trial tests

trial testing Pathology result in Pathology in 310 participants. Completed in 20 April 2020.

Timeline
1 January 2019
Primary endpoint
1 April 2020
20 April 2020

Quick facts

Lead sponsorDr. Ersin Arslan Education and Training Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment310
Start date1 January 2019
Primary completion1 April 2020
Estimated completion20 April 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dr. Ersin Arslan Education and Training Hospital

Who can join

Eligibility, any sex, with Pathology or Sigmoid Volvulus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Isolated hypoganglionosis is rare and constitutes 3-5% of all congenital neurological bowel diseases. Since hypoganglionosis is associated with symptoms such as chronic constipation or pseudo-obstruction, it can be confused with Hirschprung's disease and it is important to make a differential diagnosis before treatment. Our aim in this study; In addition to sharing the rarely isolated hypoganglionosis and sigmoid volvulus in a 45-year-old male patient with mental retardation, the investigators present a systematic comprehensive review of hypoganglionosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pathology result

Trials testing the same drug.

Other recruiting trials for Pathology

Currently open trials in the same condition.

Other Dr. Ersin Arslan Education and Training Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04363125.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing